In times when human life and quality of life remain threatened by infectious diseases, increasing microbial resistance and a diminished armamentarium of treatments, you might think that the European Commission would urgently seek and encourage alternative approaches. On the contrary, the European Food Safety Authority (EFSA) has created a panel that has ignored good science, over-ridden peer-reviewed medical studies, and seems intent on breaking the back of a validated approach to infectious disease management, namely probiotics. The recent rejection of a simple and quite bland claim related to vaginal health emphasises the travesty of this bureaucracy. Herein, the science fights back and counters the critique of EFSA.
CITATION STYLE
Reid, G. (2011). OPINION PAPER: Quo vadis – EFSA? Beneficial Microbes, 2(3), 177–181. https://doi.org/10.3920/bm2011.0026
Mendeley helps you to discover research relevant for your work.